FDA Import Refusal 1FX-3129870-7/90002/1 — GLP CERTIFIED COMPANY
The FDA refused shipment 1FX-3129870-7/90002/1 from GLP CERTIFIED COMPANY (India) on Sep 14, 2026. The refused product falls under Drugs and Biologics — FLUNIXIN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Sep 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GCF36 FLUNIXIN (ANTI-INFLAMMATORY)
- Charges
- 75